Evidence map›Paper›PMID 36497419›Full record

ArticleCancers2022

Tumour Colonisation of

Thyra Löwenmark, Anna Löfgren-Burström, Carl Zingmark, Ingrid Ljuslinder, Michael Dahlberg, Sofia Edin, Richard Palmqvist

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Oral Microbiome and Cancer.Advances in experimental medicine and biology · 2025
    Review
  9. Frontiers in immunology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. ACG case reports journal · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genetic heterogeneity of colorectal cancer and the microbiome.World journal of gastrointestinal oncology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Thyra LöwenmarkDepartment of Medical Biosciences, Pathology, Umeå University, SE-90185 Umeå, Sweden.
Anna Löfgren-BurströmDepartment of Medical Biosciences, Pathology, Umeå University, SE-90185 Umeå, Sweden.
Carl ZingmarkDepartment of Medical Biosciences, Pathology, Umeå University, SE-90185 Umeå, Sweden.ORCID 0000-0002-8627-5739
Ingrid LjuslinderDepartment of Radiation Sciences, Oncology, Umeå University, SE-90185 Umeå, Sweden.
Michael DahlbergDepartment of Surgical and Perioperative Sciences, Surgery, Umeå University, SE-90185 Umeå, Sweden.
Sofia EdinDepartment of Medical Biosciences, Pathology, Umeå University, SE-90185 Umeå, Sweden.ORCID 0000-0002-1901-8011
Richard PalmqvistDepartment of Medical Biosciences, Pathology, Umeå University, SE-90185 Umeå, Sweden.ORCID 0000-0002-9933-2843
Umeå University · SE

Funding

Lion´s Cancer Reseach Foundation LP 22-2318Swedish Cancer Society 20 1271 PjFThe Cancer Research Foundation in Northern Sweden AMP 21-1048The County Council of Västerbotten 2021, RPThe Sjöberg Foundation 2021, RP
6 · The paper itself

Abstract

Increasing evidence suggests that the gut microbiota may impact colorectal cancer (CRC) development and progression. In this study, the tumour colonisation of two CRC-associated bacteria,

Indexed as

colorectal cancerFusobacterium nucleatummucosal microbiotaParvimonas micrasurvival

Identifiers

PMID36497419
PMCPMC9736682
OpenAlexW4311049387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.